Related Experiment Videos
Temporary stents: the ACS RX flow support catheter
1Cleveland Clinic Foundation, Ohio.
Insights
Temporary stents offer coronary artery scaffolding, potentially reducing risks associated with permanent stents. Early trials show promise for the ACS RX flow support catheter, but further research is needed.
Area of Science:
- Cardiovascular Medicine
- Interventional Cardiology
- Biomedical Engineering
Background:
- Permanent stents have limitations including thrombosis and bleeding risks.
- Temporary stents aim to provide scaffolding while allowing removal before peak thrombosis risk.
- The ACS RX flow support catheter is a novel temporary stent prototype.
Purpose of the Study:
- To evaluate the efficacy and safety of the ACS RX flow support catheter.
- To assess the device's impact on angina, coronary flow, and stenosis.
- To identify factors influencing the success of temporary stenting.
Main Methods:
- Phase I and II clinical trials were conducted.
- The ACS RX flow support catheter was used in patients with suboptimal percutaneous interventional results.
- Outcomes included angina score, coronary flow, residual stenosis, and major complications.
Main Results:
- The device improved angina score, coronary flow, and decreased residual stenosis.
- Significant incidence of major complications and need for adjunctive interventions were observed.
- Efficacy and safety varied based on clinical, anatomical, and procedural factors.
Conclusions:
- The ACS RX flow support catheter shows potential for managing coronary artery dissections.
- Further studies are required to optimize its use and define predictive factors for success.
- Temporary stenting presents an alternative approach to permanent stent limitations.
Abstract:
Although permanent stents have been successfully used as bail-out devices in the treatment of abrupt occlusion, the risk of stent thrombosis and of bleeding complications, as well as the cost of a prolonged hospitalization, have been deterrents to their universal acceptance. Temporary stents were conceived to provide internal scaffolding of the coronary arteries, which could stabilize occlusive dissections, yet still allow the stent to be removed before the time of peak incidence of subacute thrombosis. The ACS RX flow support catheter is a prototype temporary stent which has been recently evaluated in phase I and II clinical trials. The device is effective in improving angina score, coronary flow, and decreasing residual stenosis when used in cases of suboptimal percutaneous interventional results. However, the incidence of major complications and the need for adjunctive percutaneous interventions remain significant. Further studies are needed to define the optimal time of cage expansion as well as the clinical, anatomical, and procedural factors that predict efficacy and safety of this new device.